NCT06925724 A Study of Ivonescimab in People With Endometrial and Cervical Cancers Status RECRUITING Phase PHASE2
NCT06877650 First-in-Human Investigation of JMT108 Injection in Participants With Advanced Malignant Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT06868732 Evaluation of JSKN016 Combination Therapy in Subjects With NSCLC Status RECRUITING Phase PHASE1
NCT06846346 Testing Ivonescimab in Combination With Chemotherapy in Advanced or Metastatic Gastric/Gastroesophageal Adenocarcinoma Status RECRUITING Phase PHASE2
NCT06844422 Adapted Guided Stereotactic Body Radiotherapy Combined With Chemotherapy and Enhancement of Novel Drug Ivonescimab for Pancreatic Cancer (ASCEND) Status RECRUITING Phase PHASE1/PHASE2
NCT06840834 Evaluating Ivonescimab as a Potential Treatment for Pleural Mesothelioma Patients Whose Cancer Has Returned After Previous Immunotherapy and Chemotherapy Status RECRUITING Phase PHASE2
NCT06814067 Phase II Multi-centered Study of Perioperative Ivonescimab Versus Pembrolizumab Combined with Standard of Care (SOC) in Patients with Resectable, Locally Advanced Head and Neck Squamous Cell Carcinoma Status NOT_YET_RECRUITING Phase PHASE2
NCT06805617 A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland Cancers Status RECRUITING Phase PHASE2
NCT06802666 Short-course Radiotherapy Followed by AK112 and CAPOX as Neoadjuvant Therapy for Locally Advanced Rectal Cancer Status RECRUITING Phase PHASE2
NCT06790212 Neoadjuvant CAPOX Plus Ivonescimab Versus CAPOX for Locally Advanced Colon Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT06769971 Phase II Study of Ivonescimab and Cadonilimab in Combination with Chemotherapy in Patients with ES-SCLC Status RECRUITING Phase PHASE2
NCT06672575 A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma Status RECRUITING Phase PHASE1/PHASE2
NCT06567314 Phase 2 Study of Ivonescimab in Patients With Cutaneous Squamous Cell Carcinoma Status RECRUITING Phase PHASE2
NCT06529718 Testing Ivonescimab Versus FOLFOX in Advanced Biliary Tract Cancer Patients Status RECRUITING Phase PHASE2
NCT06491472 Ivonescimab(AK112/SMT112) in Combination With Stereotactic Body Radiation Therapy and Chemotherapy in Patients With Pancreatic Cancer Status RECRUITING Phase PHASE2
NCT06478043 A Study to Investigate the Efficacy and Safety of Ivonescimab Combined With Irinotecan Liposome as Second-line Regimen for SCLC Status COMPLETED Phase PHASE2
NCT06196697 AK104 in Combination With AK112 Plus Chemotherapy(SOX/XELOX) as First-line Treatment for Advanced G/GEJ Cancer Status RECRUITING Phase PHASE2
NCT05582499 Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy Status RECRUITING Phase PHASE2